Literature DB >> 22334221

An evaluation of repeat stool testing for Clostridium difficile infection by polymerase chain reaction.

Sahil Khanna1, Darrell S Pardi, Jon E Rosenblatt, Robin Patel, Patricia P Kammer, Larry M Baddour.   

Abstract

GOALS: To evaluate the yield of repeat stool polymerase chain reaction (PCR) testing in patients with suspected Clostridium difficile infection (CDI).
BACKGROUND: CDI is a major challenge in health care due to its frequent occurrence and high associated costs. Enzyme immunoassay and PCR are commonly performed diagnostic tests for CDI.
METHODS: Our microbiology laboratory database was queried from January 1, 2008 to June 30, 2010 for all patients who underwent PCR stool testing for suspected CDI. Data collected included age, sex, number of stool tests performed within a 14-day period after the first test, and location of patient (inpatient vs. outpatient). Analyses were performed using JMP version 9.0.1.
RESULTS: PCR testing was performed in 15,515 patients. The median age was 58.3 years (range, 10 d to 104.3 y) and 46.2% of patients were women. Repeat testing was infrequent; 87.3% of patients had testing performed only once in a 14-day period. Increased age, male sex, and inpatient location were predictors of repeat testing. The median time between an initial test and the first repeat test was 5 days. After an initial negative test, the percentage of patients having a subsequent positive test was low (2.7% in 7 d and 3.2% in 14 d). The percentage of repeat tests that was positive within 7 days (2.9%) was lower than the percentage that was positive from day 8 to day 14 (4.8%, P=0.05).
CONCLUSIONS: Repeat testing for C. difficile has a low yield, and patients with an initial negative test should not routinely be retested.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22334221     DOI: 10.1097/MCG.0b013e3182432273

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  15 in total

Review 1.  Laboratory diagnosis of bacterial gastroenteritis.

Authors:  Romney M Humphries; Andrea J Linscott
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

2.  Characteristics and Antibiotic Use Associated With Short-Term Risk of Clostridium difficile Infection Among Hospitalized Patients.

Authors:  Sol del Mar Aldrete; Matthew J Magee; Rachel J Friedman-Moraco; Austin W Chan; Grier G Banks; Eileen M Burd; Colleen S Kraft
Journal:  Am J Clin Pathol       Date:  2015-06       Impact factor: 2.493

Review 3.  Clostridium difficile infection: new insights into management.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Mayo Clin Proc       Date:  2012-11       Impact factor: 7.616

4.  Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing?

Authors:  J L Leslie; S H Cohen; J V Solnick; C R Polage
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-20       Impact factor: 3.267

5.  Clinical characteristics of patients who test positive for Clostridium difficile by repeat PCR.

Authors:  Daniel A Green; Brie Stotler; Dana Jackman; Susan Whittier; Phyllis Della-Latta
Journal:  J Clin Microbiol       Date:  2014-08-13       Impact factor: 5.948

6.  Novel portable platform for molecular detection of toxigenic Clostridium difficile in faeces: a diagnostic accuracy study.

Authors:  J J Hirvonen; P Matero; C Siebert; J Kauppila; R Vuento; H Tuokko; S Boisset
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-17       Impact factor: 3.267

Review 7.  Clostridium difficile infection: management strategies for a difficult disease.

Authors:  Sahil Khanna; Darrell S Pardi
Journal:  Therap Adv Gastroenterol       Date:  2014-03       Impact factor: 4.409

8.  [Diagnostic workup and therapy of infectious diarrhea. Current standards].

Authors:  A Stallmach; S Hagel; A W Lohse
Journal:  Internist (Berl)       Date:  2015-12       Impact factor: 0.743

9.  Clinical factors associated with development of severe-complicated Clostridium difficile infection.

Authors:  Raina Shivashankar; Sahil Khanna; Patricia P Kammer; W Scott Harmsen; Alan R Zinsmeister; Larry M Baddour; Darrell S Pardi
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-20       Impact factor: 11.382

10.  Clinical predictors of recurrent Clostridium difficile infection in out-patients.

Authors:  R Shivashankar; S Khanna; P P Kammer; W Scott Harmsen; A R Zinsmeister; L M Baddour; D S Pardi
Journal:  Aliment Pharmacol Ther       Date:  2014-07-10       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.